SuperGen to Present at the Fifth Annual Lazard Healthcare Conference on November 18, 2008

Friday, November 14, 2008 General News J E 4
DUBLIN, Calif., Nov. 13 SuperGen, Inc.(Nasdaq: SUPG), a pharmaceutical company dedicated to the discovery anddevelopment of novel cancer therapies, today announced that James S. Manuso,Ph.D., President and Chief Executive Officer is scheduled to present at theFifth Annual Lazard Healthcare Conference on Tuesday, November 18, 2008 at theSt. Regis in New York, New York.

SuperGen's presentation at the Lazard Healthcare Conference is scheduledto begin at 4:40 p.m. EDT (1:40 p.m. PDT). A live webcast of the presentationwill be available on the investor relations section of the Company's Web siteat The webcast will be archived for 90 days.

About SuperGen

Based in Dublin, Calif., SuperGen, Inc. is a pharmaceutical companydedicated to the discovery and development of novel cancer therapies. SuperGenis developing a number of therapeutic anticancer products focused on kinaseand cell signaling inhibitors and DNA methyltransferase inhibitors. For moreinformation about SuperGen, please visit SuperGen, Inc. Dorland Global Public Relations Timothy L. Enns Michael Beckerich (Media) SVP, Corporate Communications Tel: (212) 677-7632 & Business Development Tel: (925) 560-2810 Email:

SOURCE SuperGen, Inc.


You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
PLC Systems Reports Third Quarter 2008 Results
Echo Therapeutics to Present Clinical Study Result...